Scott IC - Search Results

1

The Impact of Targeted Rheumatoid Arthritis Pharmacologic Treatment on Mental Health: A Systematic Review and Network Meta-Analysis.

Matcham F, Galloway J, Hotopf M, Roberts E, Scott IC, Steer S, Norton S. Matcham F, et al. Among authors: scott ic. Arthritis Rheumatol. 2018 Sep;70(9):1377-1391. doi: 10.1002/art.40565. Epub 2018 Jul 31. Arthritis Rheumatol. 2018. PMID: 29873196

2

Remission in early rheumatoid arthritis.

Ma MH, Scott IC, Kingsley GH, Scott DL. Ma MH, et al. Among authors: scott dl, scott ic. J Rheumatol. 2010 Jul;37(7):1444-53. doi: 10.3899/jrheum.091131. Epub 2010 Jun 1. J Rheumatol. 2010. PMID: 20516031 Review.

3

Comparative quality of life in patients with depression and rheumatoid arthritis.

Lempp H, Ibrahim F, Shaw T, Hofmann D, Graves H, Thornicroft G, Scott I, Kendrick T, Scott DL. Lempp H, et al. Int Rev Psychiatry. 2011;23(1):118-24. doi: 10.3109/09540261.2010.545368. Int Rev Psychiatry. 2011. PMID: 21338307

4

Precipitating and perpetuating factors of rheumatoid arthritis immunopathology: linking the triad of genetic predisposition, environmental risk factors and autoimmunity to disease pathogenesis.

Scott IC, Steer S, Lewis CM, Cope AP. Scott IC, et al. Best Pract Res Clin Rheumatol. 2011 Aug;25(4):447-68. doi: 10.1016/j.berh.2011.10.010. Best Pract Res Clin Rheumatol. 2011. PMID: 22137917 Review.

5

Quality of life and the outcome of established rheumatoid arthritis.

Kingsley G, Scott IC, Scott DL. Kingsley G, et al. Among authors: scott dl, scott ic. Best Pract Res Clin Rheumatol. 2011 Aug;25(4):585-606. doi: 10.1016/j.berh.2011.10.003. Best Pract Res Clin Rheumatol. 2011. PMID: 22137926 Review.

6

Payers' views on treating-to-target in rheumatoid arthritis: an English perspective.

Scott IC, Wailoo A, Scott DL. Scott IC, et al. Among authors: scott dl. Clin Exp Rheumatol. 2012 Jul-Aug;30(4 Suppl 73):S85-90. Epub 2012 Oct 16. Clin Exp Rheumatol. 2012. PMID: 23078814

7

The protective effect of alcohol on developing rheumatoid arthritis: a systematic review and meta-analysis.

Scott IC, Tan R, Stahl D, Steer S, Lewis CM, Cope AP. Scott IC, et al. Rheumatology (Oxford). 2013 May;52(5):856-67. doi: 10.1093/rheumatology/kes376. Epub 2013 Jan 3. Rheumatology (Oxford). 2013. PMID: 23287363 Review.

8

Predicting the risk of rheumatoid arthritis and its age of onset through modelling genetic risk variants with smoking.

Scott IC, Seegobin SD, Steer S, Tan R, Forabosco P, Hinks A, Eyre S, Morgan AW, Wilson AG, Hocking LJ, Wordsworth P, Barton A, Worthington J, Cope AP, Lewis CM. Scott IC, et al. PLoS Genet. 2013;9(9):e1003808. doi: 10.1371/journal.pgen.1003808. Epub 2013 Sep 19. PLoS Genet. 2013. PMID: 24068971 Free PMC article.

9

Can we discontinue synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis?

Scott IC, Kingsley GH, Scott DL. Scott IC, et al. Among authors: scott dl. Clin Exp Rheumatol. 2013 Jul-Aug;31(4 Suppl 78):S4-8. Epub 2013 Oct 3. Clin Exp Rheumatol. 2013. PMID: 24129128 Review.

10

Spleen tyrosine kinase inhibitors for rheumatoid arthritis: where are we now?

Scott IC, Scott DL. Scott IC, et al. Among authors: scott dl. Drugs. 2014 Mar;74(4):415-22. doi: 10.1007/s40265-014-0193-9. Drugs. 2014. PMID: 24610702 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters